Similar companies
| Company | Stocktwits Subscribers | |
|---|---|---|
 |
AmgenAMGN |
14,871 0% |
 |
Gilead SciencesGILD |
77,636 0% |
 |
Catalyst PharmaceuticalsCPRX |
15,584 0% |
 |
Inovio PharmaceuticalsINO |
92,109 0% |
 |
Anavex Life SciencesAVXL |
24,019 0% |
Tvardi Therapeutics Stocktwits Subscriber Count
Tvardi Therapeutics (TVRD) has 438 subscribers on Stocktwits, up 62.8% over the past three months. A growing subscriber base points to rising retail investor interest in the stock.
With 438 subscribers, Tvardi Therapeutics has a smaller Stocktwits following than Amgen (14,871) and Gilead Sciences (77,636).
Unlike daily Stocktwits mentions, which spike around news and earnings, subscriber count reflects sustained, long-term interest from the retail investor community.
How TVRD’s Stocktwits Community Feeds the AI Score
Stocktwits subscriber count is a direct read on the size of the retail investor community tracking TVRD. It is not a stock price on its own, but sustained growth in subscribers can reflect building retail interest. AltIndex feeds Tvardi Therapeutics’s Stocktwits community into the TVRD AI Score as one of 25+ alternative data signals, weighed against sentiment, Reddit activity, and fundamentals.
For daily discussion volume, see TVRD Stocktwits mentions. For other retail-community metrics, see Reddit subscribers and Reddit mentions.
Month over Month
| Jul 2026 | 434 | |
| Jun 2026 | 268 | |
| May 2026 | 267 |
Tvardi Therapeutics Stocktwits Subscribers: Frequently Asked Questions
Tvardi Therapeutics (TVRD) has 438 subscribers (438) on Stocktwits, based on AltIndex’s tracking of the stock’s Stocktwits page.
Tvardi Therapeutics's Stocktwits subscriber base is growing, up 62.8% over the past three months. View the trend chart above for the full history.
Stocktwits subscriber count is a proxy for the size of the retail investor community tracking a stock. Unlike daily mentions, which spike around news, subscriber growth reflects sustained interest. No single data point predicts a stock on its own, which is why AltIndex combines TVRD’s Stocktwits community with sentiment, Reddit activity, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Tvardi Therapeutics underperforms its industry peers when it comes to Stocktwits Subscribers, ranking dead last.
StockTwits is a social media platform designed specifically for the investing community. It enables investors and traders to share market insights, strategies, and real-time news updates. Essentially, it's a specialized network for financial market discussions, often characterized by brief, tweet-like posts.
Sign up and get more insights on Tvardi Therapeutics.
See Tvardi Therapeutics’s complete stocktwits subscribers history
Sign up to unlock 1-year and all-time charts for TVRD — plus 25+ alternative data signals, AI Scores, and real-time alerts.
Sign up
